Research Impact

h-index

N/A

Research impact score

Publications

Total publications

Trial Results

Published trial results

Citations

Total citations

Drug Portfolio

DRUG(1)

MIXED(1)

Lanreotide

1 trial

phase_3

assistance-publique-hôpitaux-de-paris

saline

1 trial

phase_3

assistance-publique-hôpitaux-de-paris

2 unique interventions2 categories

Analytics

Trial Phases

Phase 31

Trial Status

Completed1

Role Distribution

Principal Investigator1

PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT02127437Phase 3Completed

Lanreotide In Polycystic Kidney Disease Study

Autosomal Dominant Polycystic Kidney Disease (ADPKD

PrincipalinvestigatorStart date: 2014-09-19

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Autosomal Dominant Polycystic Kidney Disease (ADPKD)1

Affiliations

Necker hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Amir Abdipour, MD

Loma Linda University Health

Moderately Similar

2 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Similarity Score30%

Andreas L. Serra, MD

University of Zurich

Moderately Similar

1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Similarity Score30%

Ron Gansevoort, MD, PhD

University Medical Centre

Moderately Similar

1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Similarity Score30%

Osama Amro, MD

Tufts Medical Center

Moderately Similar

1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Similarity Score30%

Ronald Perrone, MD

Tufts Medical Center

Moderately Similar

1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Similarity Score30%

Norberto Perico, MD

Mario Negri Institute for Pharmacological Research

Moderately Similar

5 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Similarity Score30%

Richard Fatica, MD

The Cleveland Clinic

Moderately Similar

1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Similarity Score30%

Manish Sinha, PhD, MRCP (UK), MRCPCH

King's College London

Moderately Similar

1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Similarity Score30%

Giuseppe Remuzzi, M.D.

Istituto Di Ricerche Farmacologiche Mario Negri

Moderately Similar

11 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Similarity Score30%

Thomas Weimbs, PhD

Santa Barbara Nutrients

Moderately Similar

1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02127437Phase 3PrincipalInvestigator

Lanreotide In Polycystic Kidney Disease Study

Autosomal Dominant Polycystic Kidney Disease (ADPKD

Completed

All 1 trials loaded